Skip to main content
. 2022 Aug 30;151(12):2161–2171. doi: 10.1002/ijc.34257

FIGURE 1.

FIGURE 1

Frequency of ROS1 rearrangements and fusion partners in CRC. (A) Prevalence of ROS1 fusions in CRCs; 0.08% of CRC samples harbored ROS1 genomic rearrangements. (B) 5′ fusion partners of ROS1 across 34 identified CRC cases with ROS1 genomic rearrangements. (C) Prevalence of genomic ROS1 rearrangements across different tumor entities within the FMI solid tumor cohort. The overall frequency of ROS1 rearrangements is analyzed solid tumors is 0.23%. CRC, colorectal cancer; FMI, Foundation Medicine, Inc; RE, rearranged